Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma

PURPOSE: We tested the hypothesis that the combination of tremelimumab and interferon alfa-2b acting via different and possibly synergistic mechanisms would overcome tumor immune tolerance and lead to significant and durable clinical responses. PATIENTS AND METHODS: We conducted a phase II study in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tarhini, Ahmad A., Cherian, John, Moschos, Stergios J., Tawbi, Hussein A., Shuai, Yongli, Gooding, William E., Sander, Cindy, Kirkwood, John M.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2012
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3422533/
https://ncbi.nlm.nih.gov/pubmed/22184371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.37.5394
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars